The Secret Weapon You Need for This Bull Market
There's a powerful tool that can remove all the guesswork from trading. It's built to trade the key levels for you, buying dips and selling at the right time, without you having to lift a finger. For a limited time, the creators of this incredible tool are holding a free Workshop where you can see the software in action.
Financials
| Curr Year EPS Estimate | 3.27 |
| Next Quarter EPS Estimate | 0.68 |
| Profit Margin | -0.11 |
| Return on Assets | -0.04 |
| Return on Equity | -0.11 |
| Revenue | 2,666,702,080 |
| Earnings Per Share | -1.36 |
| Revenue Per Share | 12.23 |
| Gross Profit | 276,631,000 |
| Quarterly Revenue Growth | 0.36 |
General
| Name | Incyte Corporation |
| Ticker | INCY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 1,773 |
About Incyte Corporation
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor for the treatment of adults; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a drug that is in Phase III clinical trial for steroid-refractory chronic graft-versus-host-diseases (GVHD); itacitinib, which is in Phase III clinical trial to treat naïve chronic GVHD; and pemigatinib that is in Phase II clinical trial for treating bladder cancer, cholangiocarcinoma, 8p11 myeloproliferative syndrome, and Tumor agnostic. In addition, the company engages in developing Parsaclisib, which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. Additionally, the company develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer, as well as in Phase II clinical trials for patients with non-small cell lung cancer. It has collaboration agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; Agenus Inc.; Calithera Biosciences, Inc; MacroGenics, Inc.; Merus N.V.; Syros Pharmaceuticals, Inc.; Innovent Biologics, Inc.; Zai Lab Limited; and Cellenkos, Inc., as well as clinical collaborations with MorphoSys AG and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.
Earnings
Donald Trump Victory Week: These 10 Large Cap Stocks Were the Biggest Gainers
The 10 top-performing large-cap stocks last week.
One Tech Tip: Replacing passwords with passkeys for an easier login experience
LONDON (AP) — If you're tired of memorizing passwords, then give passkeys a try.
[Breaking] Classified Wargames Reveal Grave Threat From China - Ad
In multiple wargames, U.S. forces were overwhelmed and unable to stop Chinese amphibious assaults from seizing the island. With tensions at a boiling point, the economic fallout could be devastating. Get the details on the weapons makers set to boom if war breaks out.
MLBPA, FanDuel settle lawsuit over alleged improper use of name, image and likeness
NEW YORK (AP) — A commercial affiliate of the Major League Baseball Players Association settled a lawsuit with FanDuel on Friday over the alleged unauthorized use of the names and images of MLB players on its sports-betting platform.
Comcast to spin off cable networks, once star performers at the entertainment giant
Comcast will spin off many of NBCUniversal’s cable television networks, including USA Network, CNBC and MSNBC, into a separate public company.
A $50 Backdoor Play On Elon's Next "Super-IPO"? - Ad
Elon Musk has become Trump's most trusted advisors. According to one legendary investor... We are leading up to the world's first "Super-IPO" -- a company creating over $100 billion on the first day it goes public! Knowing about this "backdoor" play could be the best way to profit before the IPO...Starting with as little as $50.
Family of worker killed in Kentucky plant blast mourns and hires attorneys to investigate
LOUISVILLE, Ky. (AP) — The family of a worker killed last week in an said Monday they begged authorities to search the wreckage for his remains after they were told all employees were accounted for.
Mike Tyson Discloses Near-Death Experience Before Jake Paul Fight
In a shocking revelation, boxing legend Mike Tyson disclosed that he had a near-death experience just months before his fight with Jake Paul.
Grab Your Free Bitcoin Now! (Limited Time) - Ad
The crypto bull market is heating up, and now's the perfect time to grab your free Bitcoin. Just attend one of this week's exclusive workshops, immerse yourself in the knowledge, and complete a short quiz. $10 in BTC will be sent straight to your crypto wallet.
Ted Cruz Says Running DOGE Won't Be A Cake Walk, Offers Reading Advice To Elon Musk
Senator Ted Cruz (R-Texas) anticipated the newly established Department of Government Efficiency (DOGE) department to yield “good results” but warned that Elon Musk and Vivek Ramaswamy would have their work cut out.
Chinese hackers target Tibetan websites in malware attack, cybersecurity group says
BANGKOK (AP) — A hacking group that is believed to be has compromised two websites with ties to the Tibetan community in an attack meant to install malware on users' computers, according to findings released Wednesday by a private cybersecurity firm.
Bill Gates' Mysterious New AI Project Revealed - Ad
Tech expert Jeff Brown uncovers Bill Gates' latest AI project, Stargate, which Forbes claims could reshape everything we think we know about our world.
Working Well: The simple act of taking deep breaths can reduce stress and anxiety
NEW YORK (AP) — A simple, uncommon ritual starts each staff meeting at Myosin Marketing. When everyone is gathered , and before they get to the meat of the agenda, CEO Sean Clayton leads his team through .
Stock Of The Day: Is Pfizer Set Up To Rally?
Shares of Pfizer (PFE) may be about to reverse and head higher. They are both oversold and at a support level.
Forget Nvidia, Apple, Tesla, and Google - Ad
Market Wizard Larry Benedict: "Forget 99% of stocks: It's possible to make all the money you need for a happy retirement with just this one."
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill
Trump's decision to appoint Kennedy, known for his vaccine skepticism, has sparked significant attention.
T-Mobile Hit By Chinese Hackers After Rivals AT&T, Verizon Suffer Breach: Report
A major cyber-espionage operation linked to Chinese intelligence has reportedly infiltrated T-Mobile and other telecom networks.
The Dark Truth About AI Stocks - Ad
All the signs show the AI market is about to reverse. And unless you know what's really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too.
Judge blocks Biden administration's rule to expand overtime pay for millions
NEW YORK (AP) — A federal judge in Texas has blocked a new rule from the Biden administration that would have expanded access to overtime pay to millions more salaried workers across the U.S.
Mississippi Gulf Coast restaurant and its co-owner are sentenced for mislabeling seafood
GULFPORT, Miss. (AP) — A Mississippi Gulf Coast restaurant and its co-owner it were sentenced Monday on federal charges of as local premium fish.
Trump's Win Sets America on a New Path -- Are You Prepared? - Ad
With Trump back in office, America is on the verge of major change. The policies and decisions made in the next few months could impact your financial future more than any election in history. From massive job losses to shifting economic power -- this era of change could lock many Americans into a new underclass. But if you act today, you could protect and grow your wealth while others are left behind.
As US ramps up nuclear power, fuel supplier plans to enrich more uranium domestically
OAK RIDGE, Tenn. (AP) — A supplier of fuel for nuclear power plants announced a $60 million expansion in Tennessee on Wednesday, promising to resume and grow its manufacturing of high-tech centrifuges there to enrich uranium at its facility in Ohio.
Nvidia Set For Gains From AI Cloud Demand, Blackwell Launch, And Data Center Expansion: Analyst
Analyst maintains Outperform rating on Nvidia, raises price target to $175 ahead of strong Q3 results driven by demand for AI accelerators.
Elon Musk: "AI Will Run Out of Electricity ... in 2025" - Ad
This AI boom is going to push America's power grid to the brink... Elon Musk even recently said that AI could run out of electricity by 2025. This crisis may just reveal one of the greatest investment ideas we are ever going to find. My research has recently uncovered two companies that could make a massive difference today.
Swiss esports event canceled after 3 squads pull out over host team founder's anti-abortion comment
GENEVA (AP) — An event billed as Switzerland's biggest esports competition has been canceled after the host team's founder posted an anti-abortion comment on social media, triggering outrage that led three rival squads to pull out.
Trump's Post-Election Rally Fades, Dollar Surges To Over 1-Year Highs, Powell Puts December Interest Rate Cut Into Question: This Week In The Market
Wall Street faces reality check as post-election rally falters. Republicans' win gives Trump freedom to shape economic policy, but uncertainty remains.
Red-Hot AI Stock "Disappearing" Soon? (Get In Now) - Ad
Right now, there's an AI stock on the verge of being snapped up by a giant company... And when it does, its price could go flying. The potential gains could be astronomical. You want to get in before that happens... Otherwise the opportunity could pass you by. Your window to buy in is right now...
What's Going On With NIO Stock Today?
NIO Inc.'s stock is rising after the company reported strong demand for its Onvo L60 electric vehicle, reduced delivery times, and plans for international expansion, including entry into Azerbaijan.
Bull doge! Dogecoin soars as Trump announces a government efficiency group nicknamed DOGE
NEW YORK (AP) — Wow, much bull market.
Sam Altman, Bill Gates and More Are Making Some Strange Investments - Ad
As a Silicon Valley insider, Michael Robinson's uncovered an even bigger story than AI... A mysterious investment that could be the savior of the tech industry. Big Tech executives -- including Sam Altman, Bill Gates and Mark Zuckerberg -- are throwing large sums of money at it. This is the next frontier of tech investing...
Christie On Trump's Cannabis Plans, Elon Musk's New Role In Trump Team, Pentagon Overhaul Plans And More: This Week In Politics
The weekend was a whirlwind of political and business news.
Sig Sauer ordered to pay $11 million to Philadelphia man wounded by pistol that went off by itself
A Philadelphia jury awarded $11 million on Wednesday to a man whose holstered Sig Sauer pistol went off by itself while he was going down the stairs, causing a serious leg injury — the second major verdict this year against the embattled gun manufacturer over its P320 model.
24/7 Automated Profits in Crypto - Ad
All key indicators are flashing the same signal: an altcoin season is fast approaching. Access this exclusive workshop for early access to their next set of altcoin picks, a step-by-step blueprint for finding the next big altcoin winners, and a sneak peak at their crypto trading system with a 90% win rate.
Ben & Jerry's lawsuit accuses parent company of censorship over Gaza
Ben & Jerry’s has sued its parent company Unilever accusing it of silencing the ice cream maker from making statements in support of Palestinians in the Gaza war.
Waymo Maybe Too Small For Alphabet Investors To Care About Today, But The Self-Driving Spinoff's Could Be Valued At $850B By 20230, Says Gene Munster
Gene Munster, Managing Partner at Deepwater Asset Management, projects that Alphabet will spin out its autonomous driving unit Waymo within the next 2-4 years, potentially reaching a valuation between $350 billion and $850 billion by 2030.
Buffett, Bloomberg, & 48 Congress Members Are Buying 1 Sector - Ad
Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, "The Walmart Family", Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market... The last time we saw the world's wealthiest investors move their cash into this corner of the market, Stocks exploded 2,020%, 5,609% Even as high as 8,437% in just ONE year. Now, it's all happening again.
Trump Responds 'TRUE!' To Conservative's Claim That Military Will Be Used Against Immigrants
Twice-impeached Trump often makes graphic criticisms of migrants, including unsubstantiated claims that linked them to crime and violence.
Man pleads guilty to stealing millions from major Detroit nonprofit
DETROIT (AP) — A man from a Detroit nonprofit group pleaded guilty Friday to financial crimes that stunned the organization and forced some delays in a major riverfront project.
Wall Street Legend Issues Inauguration Buy Alert - Ad
If you've underperformed this raging bull market, if you've lost money or missed out... this is your final chance to potentially profit.
Stock market today: Asian markets mostly lower as worries over Russia-Ukraine war loom
HONG KONG (AP) — Asian stocks were mostly lower on Tuesday, despite gains on Wall Street, as worries mounted over
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.